Public Policy Alert


BioNJ Submits Prescriber Ban Comments
 
BioNJ today submitted  comments today  to the New Jersey Attorney General's office on proposed amendments to the State's limitation on prescriber compensation from pharmaceutical manufacturers. The underlying limitations -- better known as the P rescriber " G ift B an" -- were formalized in January 2018 under the previous administration.
 
Our comments recognized that the proposed amendments would provide for an increase in the modest meal amount for dinners and exceptions toward the $10,000 cap for activities educational in nature , h owever, also note d that the ban itself could serve to further the "brain drain" seen in New Jersey's academic medicine and research communities in recent years.
 
Click here for a copy of BioNJ's comments to the Attorney General's office.
BioNJ encourages interested parties to submit comments on the proposed amendments before the October 5 submission deadline. Comments should be submitted electronically via [email protected] to Maryann Sheehan, Director, Legislative and Regulatory Affairs, Division of Consumer Affairs, 124 Halsey Street, 7th Floor, PO Box 45027, Newark, New Jersey 07101. 

Please contact John Slotman, BioNJ's Vice President, Government Affairs, at [email protected]   or 609.890.3185 with questions.
Thank You to Our Public Policy Sponsors



We Work for Health of New Jersey
If you would like information on how your organization can support our public policy efforts or how to develop an employee advocacy program, please contact John Slotman, BioNJ Vice President, Government Affairs, at  [email protected]

For information on BioNJ Membership, please contact Edie Esposito at [email protected] or visit www.BioNJ.org.